UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15 (d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): August 31,2009
MILLENIA
HOPE INC.
(Exact
name of registrant as specified in its charter)
Delaware
(State or
other jurisdiction of incorporation)
(Commission
file
no.) (IRS
Employer Identification No.)
98-0213828
2711,
CENTREVILLE ROAD, BUREAU 400
WILMINGTON,
DELAWARE 19808
Postal
address:
490 du
Parc Industriel suite 202
Longueuill,
Quebec J9V 3V6
Company's
telephone number, including area code: (514) 846-5757
Item
1.01 Entry into a Definitive Material Agreement
As of
August 31, 2009 First Asian Investment Corp (FAIC) had advanced $91,000 to the
Company to fund the $91,000 previously due from the Company to SOCPRA for the
company’s purchase of the Bradykinin patent license. First Asian Investment Corp
had also undertaken to make a best effort to procure funding for the Bradykinin
research project, up to $3 million Cdn. The Company and FAIC agreed that, in
return for the aforementioned $91,000 and funding commitment, the Company would
give FAIC 70 million post reverse- split shares of Millenia Hope, as well as 74%
of its wholly owned subsidiary company, Genesis Biopharma Inc who owns the
Bradykinin license.
Item
2.02 Material Impairments
The
Company is contemplating legal action against certain former Officers/Directors
of the Company who are not respecting their signed Confidentiality and
Non-circumvent agreements.
Item
3.03 Material Modifications to Rights of Security Holders
As of
November 9, 2009 the Company received its authorization from FINRA and proceeded
to reverse split its shares in a ratio of 1:7. This will allow us to
issue further shares to the NIR group and keep us in compliance with the lending
agreement with NIR. We are seeking the aid of the NIR Group in financing the
Bradykinin project and also for our interim financing for the day- to- day
expenses and debts. These debts include a $75,000 judgement, for unpaid legal
fees to Heenan Blaikie S.E.N.C.R.L., as well as fees due to our
auditors.
Signatures
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date
November 30, 2009
|
Millenia
Hope Inc.
|
By:
/s/ Leonard Stella
|
Name
Leonard Stella
|
Its:
Chief Executive Officer
|
By:
/s/ Yehuda Kops
|
Name:
Yehuda Kops
|
Its:
Acting Chief Financial
Officer
|